Pharmaceutical Industry Today

Knee Hyaluronic Acid Injection Market to Reach USD 4.5 Billion by 2033 at a 7.2% CAGR - SRI

The Knee Hyaluronic Acid Injection market is projected to reach USD 4.5 billion by 2033, growing at a CAGR of 7.2% from 2025 to 2033, according to Strategic Revenue Insights.
Published 07 October 2026

London, UK - October 2026 | Strategic Revenue Insights Inc. - The rising prevalence of knee osteoarthritis and demand for minimally invasive pain management are supporting growth in knee hyaluronic acid injections. According to Strategic Revenue Insights, the global knee hyaluronic acid injection market is projected to reach USD 4.5 billion by 2033, registering a CAGR of 7.2% from 2025 to 2033. The report was prepared by lead analyst Kamrul Hasan. The source report does not disclose detailed methodology, including the number of primary interviews or the specific secondary datasets used.

Key Takeaways

  • Market value is projected to reach USD 4.5 billion by 2033, at a CAGR of 7.2% from 2025 to 2033.
  • Single-injection products are increasingly adopted for their convenience and reduced treatment time.
  • Improved formulations, regulatory approvals, and favorable reimbursement in developed regions are boosting penetration.
  • North America currently dominates, while Asia-Pacific is anticipated to grow fastest.
  • Named market participants include Sanofi, Seikagaku Corporation, and Zimmer Biomet.

Report URL: https://www.strategicrevenueinsights.com/industry/knee-hyaluronic-acid-injection-market

Osteoarthritis Burden Drives Non-Surgical Knee Treatment

Growth is primarily driven by the increasing prevalence of knee osteoarthritis, one of the most common joint disorders, and rising demand for minimally invasive treatment. Awareness of hyaluronic acid injections as an alternative to traditional pain management is growing.

Technological advances in formulations are improving efficacy and treatment duration. Rising healthcare spending and better access in emerging economies, together with regulatory approvals and reimbursement in developed regions, are expanding the market.

Market Segmentation

By Product Type: Single Injection, Three Injections, and Five Injections. Single-injection products are increasingly adopted.

By Application: Osteoarthritis, Rheumatoid Arthritis, and Others.

By End User: Hospitals, Orthopedic Clinics, and Ambulatory Surgical Centers.

Regional Outlook

The report covers North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America currently dominates the market, while the Asia-Pacific region is anticipated to witness the fastest growth. The source provides no further region-specific market values or growth rates.

Competitive Landscape

The report names Sanofi, Seikagaku Corporation, Zimmer Biomet, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.p.A., Anika Therapeutics, Chugai Pharmaceutical Co., Ltd., LG Chem, Smith & Nephew, OrthogenRx, and Hyaltech Ltd. as market participants.

Market Restraints

The high cost of treatment can limit access for some patients, particularly in regions with limited healthcare resources.

Related Reports

https://www.strategicrevenueinsights.com/industry/lipid-injection-market

https://www.strategicrevenueinsights.com/industry/lifesciences-cell-culture-reagent-market

https://www.strategicrevenueinsights.com/industry/lgr-antibody-market

https://www.strategicrevenueinsights.com/industry/lexapro-market

https://www.strategicrevenueinsights.com/industry/levocarnitine-market

https://www.strategicrevenueinsights.com/industry/levocabastine-market

https://www.strategicrevenueinsights.com/industry/levobupivacaine-market

https://www.strategicrevenueinsights.com/industry/levalbuterol-market

https://www.strategicrevenueinsights.com/industry/leigh-syndrome-treatment-market

https://www.strategicrevenueinsights.com/industry/keytruda-market

Frequently Asked Questions

What will be the market size by 2033?

The market is projected to reach USD 4.5 billion by 2033.

What is the expected CAGR of the knee hyaluronic acid injection market?

The market is projected to expand at a CAGR of 7.2% from 2025 to 2033.

Which segment is largest in the knee hyaluronic acid injection market?

The source does not identify a largest segment; single-injection products are increasingly adopted.

Which region leads the knee hyaluronic acid injection market?

North America currently dominates the market, while the Asia-Pacific region is anticipated to witness the fastest growth.

About Strategic Revenue Insights Inc.

Strategic Revenue Insights Inc., part of SRI Consulting Group Ltd, is a London-headquartered market intelligence firm that helps organizations across industries and geographies make evidence-based revenue and strategy decisions. The firm produces syndicated research reports and customized consulting engagements built on rigorous market sizing, forecasting, and competitive benchmarking, drawing on a globally connected team of analysts and consultants.

Media Contact Information

Company Name: Strategic Revenue Insights Inc.

Contact Person: Rohit Bhisey

Email: sales@strategicrevenueinsights.com

Phone: +44-787-740-3352

Address: Suite 10, Capital House, 61 Amhurst Road, London, E8 1LL, United Kingdom

Corporate Websites:

www.strategicrevenueinsights.com

www.strategicpackaginginsights.com

www.sriconsultinggroupltd.com

https://strategicrevenueinsights.blog/

https://medium.com/@strategic-revenue-insights.inc

https://www.strategicrevenueinsights.com/press-releases

Other Industry News

Ready to start publishing

Sign Up today!